CRKL and lung carcinoma: Here we have shown that the adaptor molecule, CRKL, is a direct miR-200bc target, functionally affecting experimental migration, invasion and metastasis of lung cancer cells and clinically prognostic of outcome in multiple tumor types from analysis of TCGA datasets.